CSI Market
Sign In | Register

Organogenesis Holdings Inc (ORGO) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access ORGO quarterly Cash Flow →
Tracking cash flow results across Organogenesis Holdings Inc to Dec 31 2021 helps illustrate how Dec 31 2025's cash generation has responded to changing business conditions.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
12 Months 		(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Operating Activities
Income37.03
Depreciation & amortization15.27
Amortization of Other Assets3.32
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Impairment of Long-Lived Assets Held-for-use0.00
Provision For Loan Losses Expensed8.21
Increase (Decrease) in Inventories-17.92
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment0.19
Share-based Compensation13.30
Income (Loss) from Equity Method Investments0.00
Gains (Losses) on Extinguishment of Debt0.00
Non Cash Interest Expense0.38
Non Cash Interest Income-
Non Cash Rent Expense Income-
Impairment Of Notes Receivable-
Write Off Of Deferred Offering Costs-
Provision For Inventory Reserve-
Fair Value Adjustment Of Interest Rate Swap-
Fair Value Adjustment Of Forfeiture Rights-
Increase Decrease In Accrued Liabilities And Other Current Liabilities10.38
Gain Loss On Extinguishment Of Underwriting Fee-
Gain Loss On Termination Of Lease-
Increase Decrease In Amortization Of Lease Liabilities15.35
Write Down To Fair Value For Asset Held For Sale11.18
Income taxes9.50
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts Receivable-115.80
Increase (Decrease) in Accounts Payable-0.53
Accrued Expense0.00
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets-0.18
Other Working Capital0.16
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities-0.15
Discontinued operations0.00
Net Cash flow from Operating Activities-10.31
Investing Activities
Capital Expenditures-14.15
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Variable Interest Entity Deconsolidation-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire Businesses, Gross0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-14.15
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.16
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-1.89
Proceeds From Related Party Short Term Debt-
Payments Receipts Of Stock Issuance Costs-
Proceeds From Repayments Of Notes Payable To Related Parties-
Proceeds From Affiliates Long Term Debt-
Payment Of Recapitalization Cost-
Redemption Of Redeemable Common Stock-
Finance Lease Principal Payments-1.17
Payment Of Recapitalizationcost-
Repayment Of Mortgage Notes Payables Real Estate Entities Net-
Payments Of Deferred Acquisition Consideration-
Proceeds From Issuance Of Senior Long Term Debts-
Landlord Assets Under Construction Net Of Tenant Allowance-
Construction Of Landlord Assets Net Of Tenant Allowance-14.46
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities-17.36
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-24.46
Total Cash Flow-41.82
4 historic quarters locked

Sign in to unlock the full Organogenesis Holdings Inc cash flow history.

Sign In Create Free Account

About Organogenesis Holdings Inc Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: February 26, 2026
  • Source: orgo-20251231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001193125-26-076730

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document 





                    


    



  Get the full CSIMarket dataset:
  Subscribe
  API
  License